Drug Transporter (DT) Information

General Information of DT
DT ID DTD0093
Gene Name SLC13A3
Protein Name Sodium/dicarboxylate cotransporter 3
Gene ID
64849
UniProt ID
Q8WWT9
TCDB ID
2.A.47.1.15
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 5ULD_A; 5UL7_A

Identity: 32.911% ; 32.41%

Minimized Score: -1021.916 kcal/mol

Detail: Structure Info

Synonyms ARLIAK; NADC3; Na(+)/dicarboxylate cotransporter 3; NaDC-3; SDCT2; SLC13A3; Solute carrier family 13 member 3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2
DT Family Divalent Anion:Na(+) Symporter (DASS) Family ;
Tissue Specificity Expression is highest in kidney. Detected inplacenta, brain, liver and pancreas.
Function This sodium-dicarboxylate cotransporter can mediates the transport of succinate and other Krebs cycle intermediates.
Endogenous Substrate(s) Dicarboxylates; Na+
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Drug-DT Affinity Assessed by Cell Line

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Alpha-ketoglutaric acid Investigative Drug Info HEK293T cells-NADC3 Km = 149 microM [1]
Succinate Investigative Drug Info HEK293T cells-NADC3 Km = 112 microM [1]
References
1 SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.